论文部分内容阅读
Clinical reports on cardiac syndrome X(CSX) have been increasing in recent years.In general, CSX does not increase the cardiovascular mortality,but it can affect the patient’s quality of life(QOL) and increase the incidence rates of cardiovascular and cerebrovascular events.Although a variety of drugs and therapies have been utilized in the clinical treatment,the management of CSX still represents a major challenge due to its unclear pathogenesis.It is necessary to explore more effective treatment programs.Many attempts have been made on trials of the Chinese medicine(CM) treatment for CSX and proved that CM has a certain advantage in efficacy to improve clinical symptoms and QOL.CM may provide a new approach for the effective treatment of CSX.
Clinical reports on cardiac syndrome X (CSX) have been increased in recent years. General, CSX does not increase the cardiovascular mortality, but it can can affect the patient’s quality of life (QOL) and increase the incidence rates cardiovascular and cerebrovascular events. Although a variety of drugs and therapies have been utilized in the clinical treatment, the management of CSX still represents a major challenge due to its unclear pathogenesis. It is necessary to explore more effective treatment programs. Many attempts have been made on trials of the Chinese medicine (CM) treatment for CSX and proved that CM has a certain advantage in efficacy to improve to clinical symptoms and QOL.CM may provide a new approach for the effective treatment of CSX.